Spot Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Spot Trading’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$209K	Buy	3,500 +500	+17%	+$30.2K	﹤0.01%	2201
2017 Q2	$237K	Buy	+3,000	New	+$245K	﹤0.01%	2114
2017 Q1	–	Sell	-8,000	Closed	-$635K	–	3374
2016 Q4	$635K	Sell	8,000 -22,000	-73%	-$1.6M	0.01%	1267
2016 Q3	$2.1M	Buy	30,000 +5,000	+20%	+$277K	0.04%	628
2016 Q2	$970K	Buy	+25,000	New	+$1.04M	0.02%	1151

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Spot Trading's EGRX Position: Q3 2017 in Review

Spot Trading opened a new position in Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2017: 1,669 shares worth $100K. The stake represents ﹤0.01% of the portfolio and ranks #2543 among its holdings. This is a return to the name: Spot Trading previously reported a position in EGRX as recently as Q4 2015.

Spot Trading first reported a position in EGRX in Q4 2015 and has held it in 2 quarters since. The position peaked at $190K in Q4 2015. 169 funds tracked by Wall St. Rank hold EGRX as of Q3 2017.

Spot Trading held 1,669 shares of Eagle Pharmaceuticals, Inc. worth $100K as of Q3 2017.
Eagle Pharmaceuticals, Inc. was a new Spot Trading position in Q3 2017.
Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2543 holding.
Spot Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2015 and has held it in 2 quarters since.
Spot Trading's Eagle Pharmaceuticals, Inc. position peaked at $190K in Q4 2015.
169 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.